Schizophrenia and Comorbid self reported Cannabis Abuse: Impact on course, functioning and services use

Journal of the Pakistan Medical Association

Volumn 57, Issue 2, 2007, Pages 60-64

  Rehman, Inayat Ur ^a   Farooq, Saeed ^a  

^a LADY READING HOSPITAL   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR CHANGE; CANNABIS ADDICTION; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; HEALTH CARE SYSTEM; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH SERVICE; PATIENT ATTITUDE; PSYCHOSIS; RELAPSE; SCHIZOPHRENIA; SOCIAL ASPECT; CASE CONTROL STUDY; FEMALE; HEALTH SERVICE; MALE; PAKISTAN; UTILIZATION REVIEW;

ADULT; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HEALTH SERVICES; HUMANS; MALE; MARIJUANA ABUSE; PAKISTAN; SCHIZOPHRENIA;

EID: 34047252141     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS, Kee K, Morrison RL, Yadalam KG: Prevalence of substance use in schizophrenia: demographic and clinical correlates. Schizophr Bull 1990; 16:31-56
2. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA 1990; 264:2511-18
3. Smith J, Hucker S: Schizophrenia and substance abuse. Br J Psychiatry 1994; 165:13-21
4. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA: Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective and affective disorders. Am J Psychiatry 1995; 152:856-61.
5. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, et al. Drug and alcohol problems among individuals with severe mental illness in South London. Br J Psychiatry 1996; 168:612-9.
6. Lehman AF, Dixon LB, eds. Double jeopardy: chronic mental illness and substance use disorders. Basel: Harwood, 1995.
7. Chaudry HR, Moss HB, Bashir A, Suliman T.. Cannabis psychosis following bhang ingestion. Br J Addict 1991; 86:1075-81.
8. Barrowclough C, Tarrier N, Lewis S, Sellwood W, Mainwaring J, Quinn J, et al. A randomised controlled effectiveness trial of a needs based psychosocial intervention service for carers of schizophrenia patients. Br J Psychiatry, 1999; 174: 505-11.
9. Veen ND, Selten JP, Van Der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis Use and Age at Onset of Schizophrenia Am J Psychiatry 2004; 161: 501-6.
10. Cantwell R. Scottish Comorbidity Study Group. Substance use and schizophrenia: effects on symptoms, social functioning and service use Br.J Psychiatry 2003; 182: 324-29.
11. Bersani G, Orlandi V, Kotzalidis GD, Pancheri P. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. Eur Arch Psychiatry Clin Neurosci 2002; 252: 86-92.
12. Lynskey. M, Hall. W. The effects of adolescent cannabis use on educational attainment: a review Addiction 2000; 95: 1621-30.
13. Gupta S, Hendricks S, Kenkel AM, Bhatia SC, Haffke EA. Relapse in schizophrenia: is there a relationship to substance abuse? Schizophr Res 1996;20:153-6.
14. Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001; 178: 116-22..
15. Tomasson K, Vaglum P. The role of psychiatric comorbidity in the prediction of readmission for detoxification. Comprehensive Psychiatry 1998; 39: 129-36.
16. Tunnicliffe, S, Harrison G, Standen PJ. Factors affecting compliance with depot injection treatment in the community. Social Psychiatry Psychiatric Epidemiology 1992; 27: 230-33.
17. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51:273-9.
18. Caspari, D. Cannabis and schizophrenia: results of a follow-up study. European archives of psychiatry and clinical neuroscience, 1999; 249: 45-9.